Have your own idea? Try our Stock Screener
In the last week, the Life Sciences industry is flat overall, with Medpace Holdings standing out by going down 9.1%. Furthermore, the industry has been flat for the past year as well. As for the next few years, earnings are expected to grow by 18% per annum.
Has the U.S. Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 01 Sep 2024 | US$749.5b | US$141.8b | US$8.5b | 37.8x | 88.2x | 5.3x |
Tue, 30 Jul 2024 | US$732.9b | US$141.0b | US$12.6b | 37.1x | 58.3x | 5.2x |
Thu, 27 Jun 2024 | US$686.9b | US$141.3b | US$12.2b | 37.9x | 56.4x | 4.9x |
Sat, 25 May 2024 | US$725.1b | US$141.5b | US$12.4b | 38.7x | 58.3x | 5.1x |
Mon, 22 Apr 2024 | US$682.2b | US$142.0b | US$12.8b | 40.8x | 53.3x | 4.8x |
Wed, 20 Mar 2024 | US$746.6b | US$142.1b | US$12.8b | 44.7x | 58.2x | 5.3x |
Fri, 16 Feb 2024 | US$722.2b | US$142.2b | US$13.0b | 43.4x | 55.5x | 5.1x |
Sun, 14 Jan 2024 | US$684.9b | US$153.9b | US$14.2b | 35.4x | 48.3x | 4.5x |
Tue, 12 Dec 2023 | US$652.7b | US$153.7b | US$14.0b | 35.4x | 46.6x | 4.2x |
Thu, 09 Nov 2023 | US$597.3b | US$153.9b | US$11.0b | 30.9x | 54.1x | 3.9x |
Sat, 07 Oct 2023 | US$644.8b | US$154.6b | US$11.2b | 33.1x | 57.6x | 4.2x |
Mon, 04 Sep 2023 | US$735.8b | US$154.6b | US$11.2b | 33.1x | 65.7x | 4.8x |
Wed, 02 Aug 2023 | US$724.5b | US$154.7b | US$11.6b | 31.5x | 62.7x | 4.7x |
Fri, 30 Jun 2023 | US$688.8b | US$152.4b | US$12.5b | 29.5x | 55.1x | 4.5x |
Sun, 28 May 2023 | US$677.4b | US$152.2b | US$12.5b | 27.7x | 54.2x | 4.5x |
Tue, 25 Apr 2023 | US$731.8b | US$154.6b | US$10.8b | 30x | 67.7x | 4.7x |
Thu, 23 Mar 2023 | US$702.4b | US$154.5b | US$10.8b | 26.2x | 64.9x | 4.5x |
Sat, 18 Feb 2023 | US$744.6b | US$154.2b | US$10.9b | 31.7x | 68x | 4.8x |
Mon, 16 Jan 2023 | US$761.5b | US$155.3b | US$8.5b | 30.6x | 89.3x | 4.9x |
Wed, 14 Dec 2022 | US$782.6b | US$155.2b | US$8.8b | 29.5x | 89.2x | 5x |
Fri, 11 Nov 2022 | US$757.7b | US$154.8b | US$8.9b | 28.2x | 85.5x | 4.9x |
Sun, 09 Oct 2022 | US$723.7b | US$152.5b | US$17.0b | 23.8x | 42.6x | 4.7x |
Tue, 06 Sep 2022 | US$753.3b | US$152.2b | US$17.3b | 28.7x | 43.5x | 4.9x |
Thu, 04 Aug 2022 | US$827.4b | US$151.7b | US$18.2b | 33.8x | 45.4x | 5.5x |
Sat, 02 Jul 2022 | US$730.4b | US$148.1b | US$20.1b | 30.3x | 36.3x | 4.9x |
Mon, 30 May 2022 | US$773.5b | US$148.1b | US$20.1b | 31.8x | 38.5x | 5.2x |
Wed, 27 Apr 2022 | US$757.0b | US$147.4b | US$25.4b | 30.2x | 29.8x | 5.1x |
Fri, 25 Mar 2022 | US$858.8b | US$146.0b | US$25.4b | 36.1x | 33.8x | 5.9x |
Sun, 20 Feb 2022 | US$825.9b | US$144.8b | US$25.4b | 37.9x | 32.5x | 5.7x |
Tue, 18 Jan 2022 | US$878.1b | US$138.0b | US$27.3b | 39.9x | 32.1x | 6.4x |
Thu, 16 Dec 2021 | US$969.4b | US$138.0b | US$27.3b | 45.6x | 35.5x | 7x |
Sat, 13 Nov 2021 | US$965.8b | US$137.8b | US$27.2b | 46.3x | 35.6x | 7x |
Mon, 11 Oct 2021 | US$710.4b | US$106.0b | US$18.5b | 46x | 38.3x | 6.7x |
Wed, 08 Sep 2021 | US$752.0b | US$106.0b | US$18.6b | 48.8x | 40.4x | 7.1x |
40.4x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.066% | |
Healthcare | 0.91% | |
Life Sciences | 0.73% | |
Clinical Research and Equipment | 0.73% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
TMO Thermo Fisher Scientific | US$615.07 | 1.5% +US$3.4b | 10.4% | PE37.8x | |
STVN Stevanato Group | US$21.88 | 17.6% +US$895.0m | -34.3% | PE44.1x | |
WST West Pharmaceutical Services | US$313.63 | 3.6% +US$787.1m | -23.1% | PE43.3x | |
BIO Bio-Rad Laboratories | US$337.32 | 7.1% +US$623.7m | -14.5% | PS3.7x | |
A Agilent Technologies | US$142.92 | 1.5% +US$560.6m | 17.2% | PE29.1x |